Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Frankfurt - Delayed Quote EUR

Medical Properties Trust, Inc. (M3P.F)

Compare
5.42
+0.01
+(0.28%)
At close: April 2 at 8:14:57 PM GMT+2
Loading Chart for M3P.F
  • Previous Close 5.40
  • Open 5.42
  • Bid --
  • Ask --
  • Day's Range 5.38 - 5.42
  • 52 Week Range 3.51 - 5.93
  • Volume 300
  • Avg. Volume 808
  • Market Cap (intraday) 3.29B
  • Beta (5Y Monthly) 1.37
  • PE Ratio (TTM) --
  • EPS (TTM) -3.72
  • Earnings Date May 7, 2025 - May 12, 2025
  • Forward Dividend & Yield 0.30 (5.47%)
  • Ex-Dividend Date Mar 10, 2025
  • 1y Target Est --

Medical Properties Trust, Inc. is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023. Since the end of the third quarter, the Company has sold four facilities and now owns approximately 43,000 licensed beds in nine countries across three continents. MPT's financing model facilitates acquisitions and recapitalizations and allows operators of hospitals to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.

www.medicalpropertiestrust.com

118

Full Time Employees

December 31

Fiscal Year Ends

Recent News: M3P.F

View More

Performance Overview: M3P.F

Trailing total returns as of 4/2/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

M3P.F
54.92%
S&P 500 (^GSPC)
3.58%

1-Year Return

M3P.F
53.98%
S&P 500 (^GSPC)
8.94%

3-Year Return

M3P.F
61.77%
S&P 500 (^GSPC)
24.75%

5-Year Return

M3P.F
38.69%
S&P 500 (^GSPC)
124.42%

Compare To: M3P.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: M3P.F

View More

Valuation Measures

Annual
As of 4/1/2025
  • Market Cap

    3.28B

  • Enterprise Value

    11.27B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.52

  • Price/Book (mrq)

    0.73

  • Enterprise Value/Revenue

    12.25

  • Enterprise Value/EBITDA

    14.51

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -232.05%

  • Return on Assets (ttm)

    1.65%

  • Return on Equity (ttm)

    -38.63%

  • Revenue (ttm)

    1.04B

  • Net Income Avi to Common (ttm)

    -2.41B

  • Diluted EPS (ttm)

    -3.72

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    335.34M

  • Total Debt/Equity (mrq)

    184.71%

  • Levered Free Cash Flow (ttm)

    649.55M

Research Analysis: M3P.F

View More

Company Insights: M3P.F

Research Reports: M3P.F

View More

People Also Watch